The Role of miR-1 and miR-133a in Bladder Cancer
Author Information
Author(s): Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M
Primary Institution: Kagoshima University
Hypothesis
miR-1 and miR-133a directly regulate TAGLN2, which may have an oncogenic function in bladder cancer.
Conclusion
The downregulation of miR-1 and miR-133a is common in bladder cancer, and these miRNAs act as tumor suppressors by targeting TAGLN2.
Supporting Evidence
- MiR-1 and miR-133a were significantly downregulated in bladder cancer.
- Transgelin 2 (TAGLN2) was identified as a direct target of both miR-1 and miR-133a.
- Silencing TAGLN2 led to significant inhibition of cell proliferation and increased apoptosis in bladder cancer cell lines.
- Immunohistochemistry showed a positive correlation between TAGLN2 expression and tumor grade in clinical specimens.
Takeaway
This study found that two tiny molecules called miR-1 and miR-133a help stop bladder cancer from growing by turning off a bad gene called TAGLN2.
Methodology
The study involved analyzing miRNA expression in bladder cancer specimens and cell lines, performing functional assays, and using luciferase reporter assays to confirm target interactions.
Limitations
The study's sample size was limited, and further research is needed to explore the clinical implications of TAGLN2 as a biomarker.
Participant Demographics
Patients included 11 bladder cancer patients for miRNA screening and 23 bladder cancer patients for quantitative RT-PCR.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website